Research / ROKU / Fundamental state Inspectable configuration
State dimensions Filing 0001428439-22-000036 General Corporate
Debt relative to revenue 43th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
10.83% · OPTIONAL · VALID
Capex intensity 79th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.79% · OPTIONAL · VALID
Operating cash generation 21th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
1.89% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
11.97% · CORE · VALID
Inventory pressure 79th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.66% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.gross_margin
46.86% · CORE · VALID
Operating margin 0th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
-19.31% · CORE · VALID
R&D intensity 93th Own-history percentile · N=14
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
27.27% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
13.01% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 11.11%
Current 10.83%
Delta -0.28% Capex Intensity Increased
Previous 4.90%
Current 5.79%
Delta 0.89% Cash Generation Increased
Previous -14.62%
Current 1.89%
Delta 16.51% Growth Decreased
Previous 18.49%
Current 11.97%
Delta -6.52% Inventory Pressure Increased
Previous 9.95%
Current 15.66%
Delta 5.71% Margin Increased
Previous 46.46%
Current 46.86%
Delta 0.40% Profitability Decreased
Previous -14.46%
Current -19.31%
Delta -4.85% R And D Intensity Increased
Previous 25.72%
Current 27.27%
Delta 1.54% Sbc Intensity Increased
Previous 11.38%
Current 13.01%
Delta 1.62% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.